Elizabeth Masson-Hurlburt
2020
In 2020, Elizabeth Masson-Hurlburt earned a total compensation of $796.3K as Executive Vice President and Head of Clinical Operations at CorMedix, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,500 |
|---|---|
| Option Awards | $332,420 |
| Salary | $291,792 |
| Other | $35,561 |
| Total | $796,273 |
Masson-Hurlburt received $332.4K in option awards, accounting for 42% of the total pay in 2020.
Masson-Hurlburt also received $136.5K in non-equity incentive plan, $291.8K in salary and $35.6K in other compensation.
Rankings
In 2020, Elizabeth Masson-Hurlburt's compensation ranked 9,520th out of 13,090 executives tracked by ExecPay. In other words, Masson-Hurlburt earned more than 27.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,520 out of 13,090 | 27th |
Division Manufacturing | 4,081 out of 5,618 | 27th |
Major group Chemicals And Allied Products | 1,661 out of 2,251 | 26th |
Industry group Drugs | 1,454 out of 1,951 | 26th |
Industry Pharmaceutical Preparations | 1,070 out of 1,456 | 27th |
Source: SEC filing on October 29, 2021.
Masson-Hurlburt's colleagues
We found five more compensation records of executives who worked with Elizabeth Masson-Hurlburt at CorMedix in 2020.